Sanara MedTech Inc. (SMTI)

Sanara MedTech Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	101.88	86.67	64.99	45.84	24.14	15.59
Revenue Growth (YoY)	30.52%	33.36%	41.77%	89.87%	54.90%	32.47%
Cost of Revenue	7.9	8.14	7.85	6.36	2.31	1.62
Gross Profit	93.98	78.53	57.14	39.48	21.83	13.97
Selling, General & Admin	81.43	74.25	56.99	46.09	28.26	18.67
Research & Development	6.79	5.7	4.13	3.07	0.36	0.04
Operating Expenses	92.54	84.36	64.8	51.53	29.21	19
Operating Income	1.44	-5.83	-7.67	-12.05	-7.38	-5.03
Interest Expense	-6.22	-3.13	-0.48	-	-0	-0.01
Interest & Investment Income	0.03	0.02	-	-	-	-
Earnings From Equity Investments	-0.69	-0.09	-	-0.38	-0.62	-
Other Non Operating Income (Expenses)	-	-	-	-	-	0.01
EBT Excluding Unusual Items	-5.44	-9.03	-8.14	-12.43	-7.99	-5.03
Merger & Restructuring Charges	-1.35	-1.35	-	-0.19	-	-
Gain (Loss) on Sale of Investments	-	-	0.25	-1.04	-	-
Asset Writedown	-0.51	-0.51	-	-	-	-
Other Unusual Items	0.96	0.97	3.45	-0.28	-	0.59
Pretax Income	-6.33	-9.91	-4.44	-13.94	-7.99	-4.45
Income Tax Expense	-	-	-	-5.84	-	-
Earnings From Continuing Operations	-6.33	-9.91	-4.44	-8.09	-7.99	-4.45
Minority Interest in Earnings	0.25	0.25	0.14	0.15	0.07	0.09
Net Income	-37.49	-9.66	-4.3	-7.94	-7.92	-4.36
Net Income to Common	-37.49	-9.66	-4.3	-7.94	-7.92	-4.36
Shares Outstanding (Basic)	9	8	8	8	7	6
Shares Outstanding (Diluted)	9	8	8	8	7	6
Shares Change (YoY)	1.70%	2.48%	4.71%	7.70%	28.02%	168.88%
EPS (Basic)	-4.36	-1.14	-0.52	-1.00	-1.08	-0.76
EPS (Diluted)	-4.36	-1.14	-0.52	-1.00	-1.08	-0.76
Free Cash Flow	-0.84	-0.23	-3.51	-5.7	-4.99	-4.58
Free Cash Flow Per Share	-0.10	-0.03	-0.42	-0.72	-0.68	-0.80
Gross Margin	92.25%	90.61%	87.92%	86.13%	90.43%	89.63%
Operating Margin	1.41%	-6.73%	-11.79%	-26.27%	-30.55%	-32.30%
Profit Margin	-36.80%	-11.15%	-6.62%	-17.32%	-32.81%	-27.95%
Free Cash Flow Margin	-0.83%	-0.27%	-5.40%	-12.44%	-20.65%	-29.38%
EBITDA	5.75	-1.42	-3.99	-9.67	-6.78	-4.74
EBITDA Margin	5.65%	-1.63%	-6.14%	-21.10%	-28.08%	-30.43%
D&A For EBITDA	4.32	4.42	3.68	2.37	0.6	0.29
EBIT	1.44	-5.83	-7.67	-12.05	-7.38	-5.03
EBIT Margin	1.41%	-6.73%	-11.79%	-26.27%	-30.55%	-32.30%

Updated Nov 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q